help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Published ahead of print on February 16, 2006, doi:10.1165/rcmb.2005-0408OC

Am. J. Respir. Cell Mol. Biol., Volume 35, Number 1, July 2006, 118-126

A more recent version of this article appeared on July 1, 2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2005-0408OCv1
35/1/118    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Swan, C.
Right arrow Articles by Hall, I. P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Swan, C.
Right arrow Articles by Hall, I. P

Submitted on November 4, 2005
Revised on February 14, 2006

Alternative Promoter Use and Splice Variation in the Human Histamine H1 Receptor Gene

Caroline Swan1*, Susan A Richards1, Nathalie P Duroudier1, Ian Sayers1, and Ian P Hall1

1 Division of Therapeutics and Molecular Medicine, University of Nottingham, Nottingham, Nottinghamshire, United Kingdom

* To whom correspondence should be addressed. E-mail: Caroline.swan{at}nottingham.ac.uk.

Upstream gene structure and mRNA expression of the human histamine H1 receptor gene was investigated in cells relevant to the pathogenesis of asthma, (primary cultured human airway smooth muscle cells, primary cultured bronchial epithelial cells and BEAS2B cells), and other tissues known to express histamine H1 receptors (placenta and brain). Splice variation of the 5' terminal exons gave three separate locations for novel promoters upstream of the detected transcription start sites. Further splice variants in the 5' untranslated region were also observed. Transient transfections of promoter/luciferase constructs showed these regions directed expression in human airway smooth muscle cells and BEAS2B cells. Polymorphism screening of the major regulatory regions identified a number of novel SNPs. Expression of splice variants was confirmed by real-time PCR assays. Results showed one 5' terminal exon splice variant, comprising exons B/K, expressed preferentially in all tissues. Interestingly the other 5' terminal exon splice variants showed tissue-specific patterns of expression, with variant F/K expressed negligibly (0.1%) in human airway smooth muscle cells but accounting for 19.3% and 8.3% of total expression in BEAS2B cells and differentiated human bronchial epithelial cells. Splice variant A/K was second most highly expressed in differentiated human bronchial epithelial cells (23%) whereas its expression in BEAS2B and human airway smooth muscle cells was 1.7 % and 4.4% respectively. These data suggest the use of alternative promoters directing human H1 receptor gene expression, both within and between cell types.




This article has been cited by other articles:


Home page
J. Immunol.Home page
G. Woszczek, L.-Y. Chen, S. Nagineni, S. Alsaaty, A. Harry, C. Logun, R. Pawliczak, and J. H. Shelhamer
IFN-{gamma} Induces Cysteinyl Leukotriene Receptor 2 Expression and Enhances the Responsiveness of Human Endothelial Cells to Cysteinyl Leukotrienes
J. Immunol., April 15, 2007; 178(8): 5262 - 5270.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2006 American Thoracic Society.
  Tobacco